Daniel C. Javitt, 10% Owner at NRX Pharmaceuticals, Inc. (NRXP), sold 1,568,126 shares at $1.01 ($1.6M) on 2022-07-29, disclosed to the SEC on 2022-08-02.
Open-market sale of $1.6M NRXP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.01 | 784,063 | $792K | 50.0% |
| 2 | $1.01 | 784,063 | $792K | 50.0% |
| Total | $1.01 avg | 1,568,126 | $1.6M | 100% |
| Filing → |
| NRXP | SELL | 2022-11-15 | $50K | — | Filing → |
| NRXP | SELL | 2022-06-07 | $608K | — | Filing → |